Indications
Opsonil is used to treat schizophrenia and other forms of psychosis (particularly the paranoid type), as well as mania and hypomania. It can also help manage anxiety, agitation, excitement, and violent or dangerously impulsive behaviour, usually as an add-on treatment for a short period. Other uses include relieving persistent hiccups and easing nausea and vomiting in terminal illness when other medicines haven't worked or aren't available. It is also used for childhood schizophrenia and autism.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Chlorpromazine acts as an antagonist (blocking agent) on different postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3 and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as an attenuation of extrapypramidal side-effects, but also leading to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors (antisympathomimetic properties, lowering of blood pressure, reflex tachycardia, vertigo, sedation, hypersalivation and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia, ECG-changes and loss of memory, but the anticholinergic action may attenuate extrapyramidal side-effects). Additionally, Chlorpromazine is a weak presynaptic inhibitor of Dopamine reuptake, which may lead to (mild) antidepressive and antiparkinsonian effects. This action could also account for psychomotor agitation and amplification of psychosis (very rarely noted in clinical use).
Pregnancy & Breastfeeding
Pregnancy category C. Animal studies using the oral route have shown reproductive toxicity, with dose related effects on the embryo and foetus, including increased resorptions and foetal deaths. A higher rate of malformations was seen in mice, but only at doses that were also toxic to the mother. Animal data on reproductive toxicity with the parenteral route are insufficient. In humans, the teratogenic risk of chlorpromazine has not been formally assessed. Various prospective epidemiological studies of other phenothiazines have produced conflicting findings on teratogenic risk. Chlorpromazine passes into breast milk in varying amounts, so it is not recommended for breastfeeding mothers unless the expected benefit is judged to outweigh any possible risk.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.